High-sensitivity troponin testing at the point of care
Speed and accuracy where it matters most—the wait over for hs-cTnI at the point of care.
When lives are at stake and every second is crucial, how can clinicians get the answers they need quickly? Every lost second in the emergency department has the potential to affect patient outcomes. The Atellica® VTLi Patient-side Immunoassay Analyzer provides the vital information clinicians need to aid in making decisions about patient disposition.
When ruling out a potential myocardial infarction (MI), every minute spent waiting on test results comes at a cost. Patients and their families are anxious, and clinicians and laboratory professionals are pressured to identify the problem quickly and accurately. Increased time to results adds congestion to an already busy emergency department. But what if ED staff had access to high-sensitivity troponin right at the point of care? Consider the value of adding a new tool at the clinician’s disposal that can provide high-sensitivity troponin I (hs-cTnI) results in just 8 minutes from a single fingerstick and patient interaction.
The solution is intuitive, easily integrates into the existing workflow, and gives laboratory partners centralized control over decentralized testing, so ED throughput can be improved for efficiency and confidence.
The Atellica VTLi Patient-side Immunoassay Analyzer, powered by Magnotech® Technology, will transform your chest pain assessment process to benefit patients, clinicians, and your operational workflow.
Because when it comes to assessing patients with symptoms of an MI in the ED, trust, time, and resources aren’t just valuable - they’re vital.
Improved Emergency Department Throughput
The Atellica VTLi system streamlines chest pain assessment, aiding in earlier disposition decisions for patients not having an MI and fast interventions for those who are.
The Atellica VTLi system offers hs-cTnI testing right at the point of care. Results are available in just minutes for clinicians and laboratory partners.
The Atellica VTLi system will aid in transforming your chest pain assessment process to benefit patients, clinicians, and operational workflow.
Each year millions of patients enter emergency departments presenting with symptoms of acute coronary syndrome (ACS).1 Determining the differential diagnosis of these patients takes time, and that time comes at a human cost: the anxiety felt by patients and their families as they wait for answers and pressure on the medical staff to identify the problem as quickly and accurately as possible.2 Our development goal is to provide high-sensitive troponin testing where it matters most—at the point of care. The design goal of the Atellica POC system is to enable ED staff to allocate resources to patients quicker and with more confidence.
Not available for sale in the U.S.A. The products/features (mentioned herein) are not commercially available in all countries. Their future availability cannot be guaranteed.
Product under development. Not available for sale. Product availability will vary by country.
Contents represent design goals and are subject to change.
This presentation should only be delivered to customers who have signed a nondisclosure agreement.
Zègre-Hemsey JK, Burke LA, DeVon HA. Patient-reported symptoms improve prediction of acute coronary syndrome in the emergency department. Res Nurs Health. 2018;41(5):459-468. doi:10.1002/nur.21902
Committee on Diagnostic Error in Health Care; Board on Health Care Services; Institute of Medicine; The National Academies of Sciences, Engineering, and Medicine; Balogh EP, Miller BT, Ball JR, editors. Improving diagnosis in health care. Washington (DC): National Academies Press (U.S.); 2015 Dec 29. 2. The diagnostic process. Available from: https://www.ncbi.nlm.nih.gov/books/NBK338593/
ESC Scientific Document Group, 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). European Heart Journal. Ehaa575. https://doi.org/10.1093/eurheartj/ehaa575